Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
CalciMedica, Inc.
Stephen Bardin, the Chief Financial Officer of CalciMedica, has resigned, effective immediately following the filing of the company's Form 10-Q for the quarter ended September 30, 2026. The company stated that his departure is not due to any disagreement with the firm.…more
CalciMedica, Inc.
Insider Alan Glicklich of CalciMedica, Inc. reported a change in beneficial ownership of securities effective October 1, 2026. This filing is a standard Form 4 disclosure regarding insider stock transactions.…more
CalciMedica, Inc.
Insider Evgeny Zaytsev of CalciMedica, Inc. filed a Form 4 on October 5, 2026, reporting changes in beneficial ownership of securities as of October 1, 2026. This filing serves as a mandatory disclosure of insider equity transactions to the SEC.…more
34 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
CalciMedica CFO Stephen Bardin to Resign
CalciMedica's CFO Stephen Bardin will resign following the filing of the company's Q3 2026 quarterly report. The company stated that the departure is not due to any disagreements and is for the purpose of pursuing other professional opportunities.…more
●●●●●●●● ●●●●● ●●●●●●
CalciMedica has filed to sell up to $25 million of its common stock through an at-the-market offering. This move is expected to dilute existing shareholders, negatively impacting the stock price.…more
●●●●●●●● ●●●●● ●●●●●●
CalciMedica has regained compliance with Nasdaq's minimum bid price and equity requirements. This development ensures the company maintains its listing status on the exchange.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.